Cargando…
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
Outbreaks of emerging infections, such as COVID-19 pandemic especially, confront health professionals with the unique challenge of treating patients. With no time to discover new drugs, repurposing of approved drugs or in clinical development is likely the only solution. Replication of coronaviruses...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751758/ https://www.ncbi.nlm.nih.gov/pubmed/33364957 http://dx.doi.org/10.3389/fphar.2020.582310 |